返回 Agenda
Session 6: OPDP Research Agenda Update
Session Chair(s)
Catherine Gray, PharmD
Director, Office of Prescription Drug Promotion, OMP, CDER
FDA, United States
This session is designed to help attendees gain a better understanding of the FDA/OPDP Research program and how it may contribute to guidance and policy development.
Learning Objective : At the conclusion of this session, participants should be able to:Develop and present an elevator pitch- Implement the lessons with actual networking activity
Speaker(s)
Panelists:
Kathryn Aikin, PhD, MS
FDA, United States
Senior Social Science Analyst, Research Team Lead, OPDP, CDER
Panelists
Kevin R. Betts, PhD
FDA, United States
Social Science Analyst, OPDP, OMP, CDER
Panelists
Amie O'Donoghue, PhD
FDA, United States
Social Science Analyst, OPDP, OMP, CDER
Panelist
Helen W. Sullivan, PhD, MPH
FDA, United States
Social Science Analyst, OPDP, OMP, CDER